首页> 外国专利> Oral capsule dosage forms include 0.1-3 glucose and 90-99 ligating or filling agents, which are 1:1-1:1.5 mixture of starch and manitol, as well as for the treatment or prevention or treatment of calcium, pain, disorders in the national chemical management system, etc.

Oral capsule dosage forms include 0.1-3 glucose and 90-99 ligating or filling agents, which are 1:1-1:1.5 mixture of starch and manitol, as well as for the treatment or prevention or treatment of calcium, pain, disorders in the national chemical management system, etc.

机译:口服胶囊剂型包括0.1-3%的葡萄糖和90-99%的结扎剂或填充剂,它们是淀粉和甘露醇的1:1-1:1.5混合物,以及用于治疗或预防或治疗钙,疼痛,国家化学品管理体系中的疾病等

摘要

Oral dosage form comprising pomalidomide weighs approximately 62.5 mg in an amount of 0.5 mg of pomalidomide provides Power and a Carrier and use to treat,Prevent or manage Pain, cancer, and other diseases.
机译:包含pomalidomide的口服剂型重约62.5 mg,其中0.5 mg pomalidomide提供力量和载体,可用于治疗,预防或控制疼痛,癌症和其他疾病。

著录项

  • 公开/公告号CL2011001969A1

    专利类型

  • 公开/公告日2012-07-20

    原文格式PDF

  • 申请/专利权人 CELGENE CORPORATION;

    申请/专利号CL20110001969

  • 发明设计人 TUTINO ANTHONY KELLY MICHAEL T.;

    申请日2011-08-12

  • 分类号A61K31/454;A61K9/48;A61P25/04;A61P35/00;

  • 国家 CL

  • 入库时间 2022-08-21 17:25:21

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号